*China Increased Price-Of Key starting materials(KSM)* which are used for making medicines by 10-20%. It kept unchanged the price of basic raw material and Active parmaceutical Ingredients. KSM are imported in India for making life saving antibiotics, steroids and Other medicines. Increase in price of KSM will discourage indigenous API Production in the country, making units unviable and API less competitive against Chinese Products.